Skip to content
value.today

Palomino Laboratories Inc.

🇺🇸 Goleta, California, USATechnologyFounded 2022
Total raised
$17 M
1 round on record
Latest round
$17 M
Apr 2026
First round on record
Apr 2026
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Palomino Laboratories Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2026$17 MNo. 1$10 to $50 million

Palomino Laboratories Inc.: Raise no. 1, Apr 2026

Investors in this round

76 investors had bought by the notice of May 1, 2026: 76 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $30 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,917,949
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason B. Tu · Executive Officer · Chief Accounting Officer and Treasurer
  • Jeffrey B. Shealy · Executive Officer, Director, Promoter · President and Chief Executive Officer
  • Richard B. Ogawa · Executive Officer, Director · Secretary
  • Steven B. DenBaars · Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Laidlaw & Company (UK) Ltd. (CRD 000119037) · London, United KingdomSold in all US states, and outside the US

Signed by Jeffrey B. Shealy, President and Chief Executive Officer. Newest notice filed May 1, 2026. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Palomino Laboratories Inc. chose not to state its revenue in its newest notice of a funding round (May 2026).

    SEC Form D · May 2026

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · May 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Palomino Laboratories Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Palomino Laboratories Inc.
NameRoleNamed in
Jason B. TuChief Accounting Officer and TreasurerMay 2026
Jeffrey B. ShealyPresident and Chief Executive OfficerMay 2026
Richard B. OgawaSecretaryMay 2026
Jeffrey B. ShealyPresident and Chief Executive OfficerMay 2026
Richard B. OgawaSecretaryMay 2026
Steven B. DenBaarsDirectorMay 2026
Jeffrey B. ShealyPresident and Chief Executive OfficerMay 2026
Steven B. DenBaarsPromoterMay 2026